Cargando…
Stereotactic body radiotherapy for organ-confined prostate cancer
BACKGROUND: Improved understanding of prostate cancer radiobiology combined with advances in delivery of radiation to the moving prostate offer the potential to reduce treatment-related morbidity and maintain quality of life (QOL) following prostate cancer treatment. We present preliminary results f...
Autores principales: | Katz, Alan J, Santoro, Michael, Ashley, Richard, Diblasio, Ferdinand, Witten, Matthew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831888/ https://www.ncbi.nlm.nih.gov/pubmed/20122161 http://dx.doi.org/10.1186/1471-2490-10-1 |
Ejemplares similares
-
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
por: Katz, Alan J, et al.
Publicado: (2013) -
Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
por: Katz, Alan J., et al.
Publicado: (2011) -
Stereotactic Body Radiotherapy as Treatment for Organ Confined Low- and Intermediate-Risk Prostate Carcinoma, a 7-Year Study
por: Katz, Alan Jay, et al.
Publicado: (2014) -
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study
por: Katz, Alan, et al.
Publicado: (2014) -
Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)